Welcome to NGC. Skip directly to: Search Box, Navigation, Content.


Brief Summary

GUIDELINE TITLE

Recurrent lower urinary tract infections in women.

BIBLIOGRAPHIC SOURCE(S)

  • Segal AJ, Choyke PL, Bluth EI, Bush WH Jr, Casalino DD, Francis IR, Jafri SZ, Kawashima A, Kronthal A, Older RA, Papanicolaou N, Ramchandani P, Rosenfield AT, Sandler CM, Tempany C, Resnick MI, Expert Panel on Urologic Imaging. Recurrent lower urinary tract infections in women. [online publication]. Reston (VA): American College of Radiology (ACR); 2005. 6 p. [30 references]

GUIDELINE STATUS

This is the current release of the guideline.

It updates a previous published version: ACR Appropriateness Criteria™ for recurrent lower urinary tract infections in women. Reston (VA): American College of Radiology (ACR); 2001. 6 p. (ACR appropriateness criteria). [30 references]

The appropriateness criteria are reviewed annually and updated by the panels as needed, depending on introduction of new and highly significant scientific evidence.

BRIEF SUMMARY CONTENT

 
RECOMMENDATIONS
 EVIDENCE SUPPORTING THE RECOMMENDATIONS
 IDENTIFYING INFORMATION AND AVAILABILITY
 DISCLAIMER

 Go to the Complete Summary

RECOMMENDATIONS

MAJOR RECOMMENDATIONS

ACR Appropriateness Criteria®

Clinical Condition: Recurrent Lower Urinary Tract Infections (UTIs) in Women

Radiologic Exam Procedure Appropriateness Rating Comments
X-ray, kidney, intravenous urography, IVP 6 Not cost effective in this group. May be useful if there is an uncertain history.
CT, abdomen and pelvis, with and without contrast 6 In recurrent and persistent infection, CT may be indicated to exclude structural abnormalities. MRI may be indicated if urethral diverticulum is suspected.
X-ray, abdomen, KUB 4 May be useful in patients when there is a suspicion of calculi.
CT, abdomen, helical, without contrast 3 May be useful in patients when there is a suspicion of calculi.
X-ray, bladder, cystography 2  
X-ray, bladder, voiding cystourethrography (VCUG) 2  
X-ray, urethra, retrograde 2  
X-ray, colon, barium enema 2  
US, kidney 2  
US, bladder 2  
NUC, bladder cystography 2  
MRI, pelvis 2  
MRI, urethra 2  
US, urethra 1  
Appropriateness Criteria Scale
1 2 3 4 5 6 7 8 9
1 = Least appropriate 9 = Most appropriate

Note: Abbreviations used in the tables are listed at the end of the "Major Recommendations" field.

It is estimated that 20 to 35% of all females have at least one urinary tract infection (UTI) at some time in their lives. Most occur in healthy, sexually active women with a normal urinary tract and normal renal function. These infections are usually limited to the lower urinary tract, are not recurrent, and respond to appropriate antimicrobial therapy. Lower UTIs are confined to the bladder and occasionally the urethra and result in irritative voiding symptoms such as frequency, dysuria, urgency, and hematuria in severe cases. There is usually no associated flank pain, fever, or other systemic symptoms.

Recurrent lower urinary tract infections (UTIs) are usually defined as two or more episodes of such infection occurring in the preceding 12 months. In most cases, such infections are the result of sexual habits and hygiene (e.g., women who are sexually active, especially those using diaphragms and/or spermatocides). In fact, such lower UTIs are commonly referred to as "honeymoon cystitis." A clean-catch or catheterized specimen for culture typically reveals greater than 100,000 organisms per milliliter of urine. The typical infecting organism is Escherichia coli. The route of infection is ascending from the perianal area and vagina via the urethra and into the bladder. In women, it is not at all uncommon for such infections to be severe enough to result in gross hematuria. However, in uncomplicated lower UTIs, there is complete clearing of bacteriuria and hematuria with appropriate antimicrobial therapy. In some cases, single-dose antimicrobial therapy after intercourse or at the onset of irritative voiding symptoms is adequate to control frequent recurrences of cystitis. In patients without underlying risk factors (see Table 1 in the original guideline document), and with lower urinary tract infections as defined above that do not exceed two episodes per year on average, and that respond promptly to appropriate therapy, imaging is usually not cost-effective.

Uncomplicated recurrent lower UTIs in women must be differentiated from "reinfection," which may indicate causes such as a vesicovaginal or vesicoenteric fistula or a paravesical abscess with fistula to the bladder. Furthermore, "bacterial persistence" is defined as an infection with the same organism, typically from a site within the urinary tract, after the bacteriuria has resolved for at least several days and antimicrobial therapy has ceased. Causes of bacterial persistence include calculi, foreign bodies, urethral or bladder diverticula, infected urachal cyst, and postoperative changes such as a remaining ureteral stump that retains urine and results in stasis. In such patients with frequent recurrences and reinfections with the same bacteria, imaging is indicated to detect a treatable condition and monitor its progress.

In support of the premise that imaging has little efficacy in uncomplicated lower UTIs in women, one study reported a series of 164 women with recurring UTIs who had excretory urography (IVP). Of the IVPs, 88% were completely normal, and there were no cases with abnormalities in which the findings altered the medical or surgical management. A second report studied 153 women with IVP and cystoscopy and found that 89% were entirely normal. None of the abnormalities discovered in the remaining 11% were judged to be related to recurrent infections or influenced subsequent therapy. A third report studied 78 women with recurrent UTIs and found 6% with "major structural urologic abnormalities requiring further therapy." All women with such abnormalities had risk factors (to be defined subsequently). A fourth report prospectively studied 126 women with UTIs. Most, but not all, had two or more UTIs. It was concluded that in this group radiographic and endoscopic examination would rarely uncover abnormalities that are important in the treatment of UTI. A fifth study reported on 201 young women with recurrent UTIs, of whom 121 had uncomplicated lower UTIs. The IVPs for all of the latter either were normal or showed insignificant abnormalities. They also concluded that a risk factor should be present to justify an imaging study.

Therefore, imaging studies should be reserved for women who do not respond promptly to appropriate antimicrobial therapy, those who suffer frequent reinfections (or bacterial persistence), and those with known risk factors. Documented risk factors assocated with other than uncomplicated lower UTIs include persistent hematuria, history of pyelonephritis, history of childhood urinary tract infections, flank pain, fever more than 38.5 degrees C, history of urinary calculi or urinary tract obstruction, obstructive voiding symptoms (straining to urinate, feeling of incomplete bladder emptying, etc.), infection with a urea-splitting organism, abnormal renal function studies, neurogenic bladder dysfunction, history of genitourinary surgery, asymptomatic bacteriuria, diabetes mellitus, and analgesic abuse. It should be remembered in all cases of UTI that it is often difficult to distinguish between infections associated with pathology in the upper versus the lower urinary tract. As an example, in a series of 293 patients, the most common presenting symptom in women with reflux nephropathy was lower UTI (72% of cases). The following paragraphs discuss the various imaging examinations that may be useful in evaluating women with recurrent UTIs that fall outside the category of uncomplicated.

Plain film (KUB) of the abdomen has long been an important examination for detecting calculi, bladder wall calcifications, gas in the wall or lumen of the urinary bladder, and/or foreign bodies that may be the etiology of a UTI. When calcifications are seen in the bladder wall, it is often possible to make a correct clinical diagnosis if these findings are viewed in the context of the clinical history, physical examination, appropriate laboratory studies, and further imaging of the remainder of the urinary tract. Bladder wall calcification is typically due to prior infection with schistosomiasis (uncommon in the United States, but very common in other parts of the world), tuberculosis, Cytoxan cystitis, radiation cystitis, or urothelial neoplasm (found in less than 1% of transitional cell carcinomas).

Excretory urography remains a highly effective modality for evaluating the urinary tract. The study optimally includes thin-section nephrotomography, which will generally detect a renal parenchymal mass such as an abscess that may be a focus of recurrent infection. Ill-defined renal margins may suggest a perirenal inflammatory process best evaluated by CT. However, for evaluation of the collecting system, IVP is virtually unexcelled and will correctly detect the changes caused by chronic atrophic pyelonephritis, papillary necrosis and subtle urothelial neoplasms, and other changes associated with infections such as pyelitis cystica and leukoplakia. IVP is also useful for excluding congenital anomalies or obstruction of the urinary tract. The bladder phase of the IVP can usually identify contour abnormalities suggestive of inflammation or neoplasm. Further, the ability of the bladder to empty on voiding can be reasonably assessed. However, when questions remain regarding the integrity of the bladder wall, cystoscopy is always indicated to rule out neoplasm.

Although abdominal plain-film radiography is considered the most cost-effective imaging modality for detecting opaque calculi associated with recurrent urinary tract infection, it may prove inadequate in some cases (e.g., poor definition due to moderate overlying bowel). In such instances, unenhanced helical CT may be used. In many locations, the cost of this examination has been reduced so that it is competitive with that of an IVP. Its benefits include increased accuracy in detecting calculi (spatial resolution and lack of overlying bowel and bone), increased speed of examination, and increased abdominal detail, allowing, in some cases, an alternate diagnosis to explain patients' signs, symptoms, and laboratory findings. As a result, unenhanced CT has been used predominantly for the emergency patient with "renal colic" and/or hematuria. It has also been used to define the severity and extent of upper-tract calculi, sometimes associated with recurrent UTIs. Additionally, CT without and with intravenous contrast has been very helpful and has been described as the "examination of choice" in evaluating complicated UTIs (e.g., abscess).

Some investigators have advocated the use of renal and pelvic US combined with KUB as a replacement for IVP. They conclude that young women with recurrent UTIs should have this combination of exams (i.e., US and KUB) as the investigation of choice because it is cost-effective, "non-invasive, inexpensive and acceptable to the patient." Others have supported the continued use of IVP by citing the level of experience required to perform accurate US as well as the operator dependence of this exam. Ultrasound has been shown to be equal to IVP for detecting bladder stones but less sensitive than abdominal x-ray for detecting bladder wall calcifications or distal ureteral stones. Bladder and urethral calcifications have also been detected by CT, but this examination is more costly and should not be used routinely.

Patients with suspected bladder diverticula may be imaged with IVP, cystography, or US. When a bladder diverticulum is at or near a ureteral orifice, voiding cystourethrography should be considered to evaluate the possibility of vesicoureteral reflux. Although used commonly in children to reduce the dose of radiation, nuclear cystography has not been used widely in adults.

Diverticula of the urethra can be evaluated by voiding cystourethrography (VCUG) or retrograde urethrography. Some have also advocated US and MRI for detection. Endovaginal and transperineal sonography has been suggested as a "noninvasive screening technique for female urethral diverticula." It is said to better demonstrate the "spatial relationship of the diverticula to the urethra." MRI is accurate but expensive and should be reserved for those patients in whom there is strong clinical suspicion of a diverticulum and when the more conventional modalities are equivocal.

When performing cystography and urethrography for evaluating the lower urinary tract, the use of digital radiography has been shown to decrease radiation dose by approximately 90% while maintaining diagnostic accuracy. This is particularly important in reducing the gonadal radiation dose during the examination of young women.

Enterovesical fistulae are usually caused by diverticulitis (cancer is the second most common cause). Clinical suspicion is frequently raised by the presence of UTI with pneumaturia and/or fecaluria. The diagnosis and localization usually require more than one examination. In one large series, cystoscopy and barium enema were used in 75% of the patients but were positive in only 36% of the patients and 34% of the patients, respectively. IVP was performed in 55% of the patients but was only 12.5% diagnostic; cystography was used 36% of the time and was 44% diagnostic; CT scan was used in 23% of patients and was 60% diagnostic. Colonoscopy, US, upper gastrointestinal/small bowel follow-through, sigmoidoscopy, MRI, and nuclear imaging have very low yields, making them even less cost-effective. The authors conclude that CT, cystoscopy, and oral charcoal are the most effective modalities for diagnosing the presence of a fistula. Yet, after analysis of another large series, the authors conclude that a combination of cystoscopy, cystography, and barium enema "resulted in diagnosis of all patients."

When UTI accompanies neuropathic bladder, cystography or US may demonstrate the morphologic changes of the bladder wall, and VCUG or transrectal sonographic voiding cystourethrography may document neuromuscular dysfunction of the bladder and/or associated sphincters.

Summary

Women with recurrent urinary tract infections (UTIs) should have one or more additional risk factors to justify urologic or radiologic investigation. In such cases, the abdominal plain film, US, IVP, and cystoscopy are the most common and most rewarding examinations for achieving a cost-effective diagnosis, and they continue to be the core examinations for evaluating the lower urinary tract. Abnormalities of the bladder and the urethra can also be shown with cystography and urethrography, respectively. For the detection of fistulae, contrast enema and CT scan have also been shown to be diagnostic and may supplement cystoscopy and cystography. MRI and nuclear imaging have had a very limited role in the evaluation of women with recurrent lower UTIs.

Anticipated Exceptions

Exceptions to the above guidelines occur when there is clinical confusion regarding the source of recurrent UTI or when risk factors (enumerated above and in Table 1 in the original guideline document) are present. In such cases, appropriate imaging as previously described is indicated.

Abbreviations

  • CT, computed tomography
  • IVP, intravenous pyelogram
  • KUB, kidneys, ureters, bladder
  • MRI, magnetic resonance imaging
  • NUC, nuclear medicine
  • US, ultrasound

CLINICAL ALGORITHM(S)

Algorithms were not developed from criteria guidelines.

EVIDENCE SUPPORTING THE RECOMMENDATIONS

TYPE OF EVIDENCE SUPPORTING THE RECOMMENDATIONS

The recommendations are based on analysis of the current literature and expert panel consensus.

IDENTIFYING INFORMATION AND AVAILABILITY

BIBLIOGRAPHIC SOURCE(S)

  • Segal AJ, Choyke PL, Bluth EI, Bush WH Jr, Casalino DD, Francis IR, Jafri SZ, Kawashima A, Kronthal A, Older RA, Papanicolaou N, Ramchandani P, Rosenfield AT, Sandler CM, Tempany C, Resnick MI, Expert Panel on Urologic Imaging. Recurrent lower urinary tract infections in women. [online publication]. Reston (VA): American College of Radiology (ACR); 2005. 6 p. [30 references]

ADAPTATION

Not applicable: The guideline was not adapted from another source.

DATE RELEASED

1995 (revised 2005)

GUIDELINE DEVELOPER(S)

American College of Radiology - Medical Specialty Society

SOURCE(S) OF FUNDING

The American College of Radiology (ACR) provided the funding and the resources for these ACR Appropriateness Criteria®.

GUIDELINE COMMITTEE

Committee on Appropriateness Criteria, Expert Panel on Urologic Imaging

COMPOSITION OF GROUP THAT AUTHORED THE GUIDELINE

Panel Members: Arthur J. Segal, MD (Principal Author); Peter L. Choyke, MD; Edward I. Bluth, MD; William H. Bush, Jr, MD; David D. Casalino, MD; Isaac R. Francis, MD; S. Zafar H. Jafri, MD; Akira Kawashima, MD, PhD; Alan Kronthal, MD; Robert A. Older, MD; Nicholas Papanicolaou, MD; Parvati Ramchandani, MD; Arthur T. Rosenfield, MD; Carl M. Sandler, MD; Clare Tempany, MD; Martin I. Resnick, MD

FINANCIAL DISCLOSURES/CONFLICTS OF INTEREST

Not stated

GUIDELINE STATUS

This is the current release of the guideline.

It updates a previous published version: ACR Appropriateness Criteria™ for recurrent lower urinary tract infections in women. Reston (VA): American College of Radiology (ACR); 2001. 6 p. (ACR appropriateness criteria). [30 references]

The appropriateness criteria are reviewed annually and updated by the panels as needed, depending on introduction of new and highly significant scientific evidence.

GUIDELINE AVAILABILITY

Electronic copies: Available in Portable Document Format (PDF) from the American College of Radiology (ACR) Web site.

ACR Appropriateness Criteria® Anytime, Anywhere™ (PDA application). Available from the ACR Web site.

Print copies: Available from the American College of Radiology, 1891 Preston White Drive, Reston, VA 20191. Telephone: (703) 648-8900.

AVAILABILITY OF COMPANION DOCUMENTS

PATIENT RESOURCES

None available

NGC STATUS

This summary was completed by ECRI on May 6, 2001. The information was verified by the guideline developer as of June 29, 2001. This summary was updated by ECRI on September 7, 2004. The updated information was verified by the guideline developer on October 8, 2004. This summary was updated by ECRI on February 6, 2006.

COPYRIGHT STATEMENT

DISCLAIMER

NGC DISCLAIMER

The National Guideline Clearinghouse™ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.

All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.

Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the NGC Inclusion Criteria which may be found at http://www.guideline.gov/about/inclusion.aspx .

NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.

Readers with questions regarding guideline content are directed to contact the guideline developer.


 

 

   
DHHS Logo